Test & Treat

About this entry

Test & Treat has developed a point of care technology for the detection and management (antibiotic susceptibility) of bacterial Urinary Tract Infection (UTI).

The technology is designed for point of care use, such that the physician can confidently prescribe a suitable antibiotic to treat the identified infection whilst the patient is present.

Test&Treat technology provides antibiotic susceptibility in 30mins (with sensitivity and specificity >90%) on first line antibiotic treatment of UTI. The technology, based on ATP bioluminescence, is now being commercialised in partnership with Abtek Biologicals, Liverpool.